Our Product
The goal of our company is to create a self-assessment product to accurately measure the symptom of tremor that the patient can utilize at home. The product will be a software package that utilizes the Leap, by LeapMotion, Inc. in order to create a quantitative method for 3D measurements of Parkinsonian tremor.
The Leap is a small USB peripheral that creates a 3D interaction space of 8 cubic feet for 3D, touch-free motion sensing and motion control. It has been proven that a method of 3D analysis will provide an easy to use and robust quantitative measure of tremor amplitude that will be useful for the clinician in the assessment of the patient.[1] Referring to the current gold standard assessment of PD, the Unified Parkinson Disease Rating Scale (UPDRS,) we believe that we can use the Leap as a self-assessment tool for a large portion of the assessment such as: handwriting, cutting food, handling utensils, most upper limb tremors, finger taps, and hand movements. The results of these assessments would be quantitative, but can also be correlated to a qualitative score on the UPDRS. These assessment results would then be digitally available to clinicians in order to remotely monitor the patient and professionally assess the results. Not only would the Leap, which is accurate to 0.01 mm, be more cost effective for discovering slight tremors that are not clinically obvious, but it may also be more practical than using Surface EMG recordings to discover these slight tremors.[1,2]
After accepting LeapMotion's invitation into the early admittance of the Leap Software Developer Program, we have made amazing progress. Once our prototype is complete, the clinical trials have been run, and our product is approved by the FDA, our app will be available through the Leap AirSpace for $40. The total cost of this new tremor self-assessment device (including the price of the Leap) will be $120, which is more than $400 cheaper than any other competitor product.
After accepting LeapMotion's invitation into the early admittance of the Leap Software Developer Program, we have made amazing progress. Once our prototype is complete, the clinical trials have been run, and our product is approved by the FDA, our app will be available through the Leap AirSpace for $40. The total cost of this new tremor self-assessment device (including the price of the Leap) will be $120, which is more than $400 cheaper than any other competitor product.
1. Rajaraman, V., et al. "A Novel Quantitative Method for 3d Measurement of Parkinsonian Tremor." Clin Neurophysiol 111.2 (2000): 338-43. Print.
2. Lakie, M., and W. J. Mutch. "Finger Tremor in Parkinson's Disease." J Neurol Neurosurg Psychiatry 52.3 (1989):392-4. Print.
2. Lakie, M., and W. J. Mutch. "Finger Tremor in Parkinson's Disease." J Neurol Neurosurg Psychiatry 52.3 (1989):392-4. Print.
GitHub
Click below to see other small projects we've created for the Leap: